International Journal of Antimicrobial Agents
Volume 30 , Pages 76-79 , November 2007

Short antibiotic treatment courses or how short is short?

References 

  1. Williams JD, Brumfitt W, Leigh D, Percival A. Eradication of bacteruria in pregnancy by a short course of chemotherapy. Lancet. 1965;1:831
  2. East Africa and British Research Councils. Controlled clinical trial of short-course (6 month) regimens of chemotherapy for the treatment of pulmonary tuberculosis. Lancet 1972; 1:1105–6.
  3. Guillemot D, Carbon C, Balkau B, et al. Low dosage and long treatment duration of beta-lactam: risk factors for carriage of penicillin-resistant Streptococcus pneumoniae. JAMA. 1998;279:365–370
  4. Tran TH, Bethell DB, Nguyen TT, et al. Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis. 1995;20:917–923
  5. Vinh H, Wain J, Vo TN, et al. Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother. 1996;40:958–961
  6. Parry CM, Ho VA, Phuong le T, et al. Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother. 2007;51:819–825
  7. Nathan N, Borel T, Djibo A, et al. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study. Lancet. 2005;366:308–313
  8. Briggs S, Ellis-Pegler R, Roberts S, Thomas M, Woodhouse A. Short course intravenous benzylpenicillin treatment of adults with meningococcal disease. Intern Med J. 2004;34:383–387
  9. Ellis-Pegler R, Galler L, Roberts S, Thomas M, Woodhouse A. Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. Clin Infect Dis. 2003;37:658–662
  10. Eggimann P, Pittet D. Infection control in the ICU. Chest. 2001;120:2059–2093
  11. Rosenthal VD, Guzman S, Orellano PW. Nosocomial infections in medical-surgical intensive care units in Argentina: attributable mortality and length of stay. Am J Infect Control. 2003;31:291–295
  12. Corona A, Wilson AP, Grassi M, Singer M. Prospective audit of bacteraemia management in a university hospital ICU using a general strategy of short-course monotherapy. J Antimicrob Chemother. 2004;54:809–817
  13. Corona A, Wilson AP, Grassi M, Singer M. Short-course monotherapy strategy for treating bacteremia in the critically ill. Minerva Anestesiol. 2006;72:841–857
  14. Corona A, Bertolini G, Ricotta AM, Wilson AP, Singer M. Variability of treatment duration for bacteraemia in the critically ill: a multinational survey. J Antimicrob Chemother. 2003;52:849–852
  15. Fagon JY, Chastre J, Hance AJ, et al. Detection of nosocomial lung infection in ventilated patients. Use of a protected specimen brush and quantitative culture techniques in 147 patients. Am Rev Respir Dis. 1988;138:110–116
  16. Seidenfeld JJ, Pohl DF, Bell RC, Harris GD, Johanson WG. Incidence, site, and outcome of infections in patients with the adult respiratory distress syndrome. Am Rev Respir Dis. 1986;134:12–16
  17. Chastre J, Wolff M, Fagon JY, et al. PneumA Trial Group Comparison of 8 vs. 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA. 2003;290:2588–2598
  18. el Moussaoui R, de Borgie CA, van den Broek P, et al. Effectiveness of discontinuing antibiotic treatment after three days versus eight days in mild to moderate-severe community acquired pneumonia: randomised, double blind study. BMJ. 2006;332:1355–1359

PII: S0924-8579(07)00288-9

doi: 10.1016/j.ijantimicag.2007.06.017

International Journal of Antimicrobial Agents
Volume 30 , Pages 76-79 , November 2007

Article Tools

* Image Usage & Resolution